Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMay 31, 2017Midazolam HCl all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0814-2017Class IITerminatedMay 31, 2017Ketamine HCl all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0813-2017Class IITerminatedMay 31, 2017Morphine Sulfate all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0812-2017Class IITerminatedMay 31, 2017Meperidine HCl all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0811-2017Class IITerminatedMay 31, 2017Hydromorphone HCl all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0810-2017Class IITerminatedMay 31, 2017Fentanyl Citrate all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0809-2017Class IITerminatedMay 31, 2017Sufentanil Citrate all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0808-2017Class IITerminatedMay 31, 2017ADD HEPARIN PF 50 Units ONLY TO TPN all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0807-2017Class IITerminatedMay 31, 2017Early Baby TPNLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0806-2017Class IITerminatedMay 31, 2017Early TPNLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0805-2017Class IITerminatedMay 31, 2017Standard Starter TPN all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0804-2017Class IITerminatedMay 31, 2017TPN Neonatal all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0803-2017Class IITerminatedMay 31, 2017NICU STARTER TPN all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0802-2017Class IITerminatedMay 31, 2017Ropi/ Epi/ Clon PeriCapsular injection all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0801-2017Class IITerminatedMay 31, 2017OfirmevLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0800-2017Class IITerminatedMay 31, 2017NOVA PeriCapsular injection all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0799-2017Class IITerminatedMay 31, 2017RECK PeriCapsular injection all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0798-2017Class IITerminatedMay 31, 2017Nalbuphine all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0797-2017Class IITerminatedMay 31, 2017Lidocaine all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0796-2017Class IITerminatedMay 31, 2017Ropivacaine HCl in 0.9% Sodium Chloride all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0795-2017Class IITerminatedMay 31, 2017Bupivacaine HCl in 0.9% Sodium Chloride all strengthsLabeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.Advanced Pharma Inc. · D-0794-2017Class IIOngoingMay 31, 2017Ventolin HFADefective Delivery System: Elevated number of units with out of specification results for leak rateGlaxoSmithKline, LLC · D-0793-2017Class IITerminatedMay 31, 2017Estrone, For Prescription CompoundingcGMP Deviations: lack of quality assurance at the API manufacturer.Fagron, Inc · D-0792-2017Class IITerminatedMay 31, 2017Estriol, For Prescription CompoundingcGMP Deviations: lack of quality assurance at the API manufacturer.Fagron, Inc · D-0791-2017Class IITerminatedMay 31, 2017Alprazolam Extended-release TabletsFailed Dissolution SpecificationsMylan Pharmaceuticals Inc. · D-0706-2017Class IIITerminatedMay 24, 2017Fluocinonide Cream UPSCross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.Taro Pharmaceuticals U.S.A., Inc. · D-0790-2017Class IITerminatedMay 24, 2017Milrinone Lactate in 5% Dextrose InjectionLack of assurance of sterility: customer complaints received for the presence of leaks.Baxter Healthcare Corporation · D-0789-2017Class IITerminatedMay 24, 2017Fluconazole InjectionLack of assurance of sterility: customer complaints received for the presence of leaks.Baxter Healthcare Corporation · D-0788-2017Class IIITerminatedMay 24, 2017Desoximetasone Ointment USPSuperpotent DrugTeligent, Inc. · D-0787-2017Class IITerminatedMay 24, 2017VITAMIN D3 IN OLIVE OIL SDV 100Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0786-2017Class IITerminatedMay 24, 2017VITAMIN D3 IN OLIVE OIL SDV 100Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0785-2017Class IITerminatedMay 24, 2017VITAMIN B COMPLEX 1ML SDV NA INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0784-2017Class IITerminatedMay 24, 2017TESTOST AQ MDV 50MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0783-2017Class IITerminatedMay 24, 2017TESTOST CYP SESAME OIL 5ML MDV 100MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0782-2017Class IITerminatedMay 24, 2017SOD PHENYLBUTYRATE SDV 30MLLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0781-2017Class IITerminatedMay 24, 2017SODIUM CHLORIDE INH PF GV 0.9% SOLNLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0780-2017Class IITerminatedMay 24, 2017SODIUM CARBOXYM-CELL PF 0.5% OPHTHLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0779-2017Class IITerminatedMay 24, 2017SODIUM BICARB 50ML MDV 8.4%Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0778-2017Class IITerminatedMay 24, 2017PYRIDOXAL-5-PHOS 5ML MDV 50MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0777-2017Class IITerminatedMay 24, 2017PYRIDOXAL-5-PHOS 10ML MDV 100MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0776-2017